CASP9 and cancer: It also discusses advantages and disadvantages of different approaches in anticancer immunotherapy, including immune mobilizing monoclonal T-cell receptors against cancer (ImmTAC), inducible caspase-9, and Herpes simplex virus-thymidine kinase (HSV-TK) systems.